Friday, September 30, 2011

Exciting resveratrol finding

A study appearing in the October 2011 issue of The FASEB Journal shows that resveratrol, the "healthy" ingredient in red wine, stops breast cancer cells from growing by blocking the growth effects of estrogen. This discovery, made by a team of American and Italian scientists, suggests for the first time that resveratrol is able to counteract the malignant progression since it inhibits the proliferation of hormone resistant breast cancer cells. This has important implications for the treatment of women with breast cancer whose tumors eventually develop resistance to hormonal therapy.

Researchers used several breast cancer cell lines expressing the estrogen receptor to test the effects of resveratrol. Researchers then treated the different cells with resveratrol and compared their growth with cells left untreated. They found an important reduction in cell growth in cells treated by resveratrol, while no changes were seen in untreated cells. Additional experiments revealed that this effect was related to a drastic reduction of estrogen receptor levels caused by resveratrol itself.

"These findings are exciting, but in no way does it mean that should people go out and start using red wine or resveratrol supplements as a treatment for breast cancer," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "What it does mean, however, is that scientists haven't finished distilling the secrets of good health that have been hidden in natural products such as red wine."

Steve - resveratrol is considered a phytoestrogen, so this balancing effect on breast cancer cells is not a total surprise.

Tuesday, September 27, 2011

Vitamin E Update

ALS
Long-term consumption of vitamin E supplements may reduce the risk of developing amyotrophic lateral sclerosis (ALS)—known as Lou Gehrig’s disease, according to American Journal of Epidemiology. A research team from Harvard University pooled information from the Nurses' Health Study (1976-2004), the Health Professionals Follow-up Study (1986-2004), the Cancer Prevention Study II Nutrition Cohort (1992-2004), the Multiethnic Cohort Study (1993-2005), and the National Institutes of Health-AARP Diet and Health Study (1995-2005).

Out of 1,055,546 participants, 805 developed ALS. Duration of vitamin E supplement use showed ALS rates declined with increasing years of supplement use. Compared with non-users, the multivariable adjusted relative risk was 1.05 among users of less than one year; 0.77 among those subjects using vitamin E supplements for two to four years; and 0.64 among people taking vitamin E supplements for more than five years. The benefit persisted even after adjusting for other lifestyle factors such as weight, smoking habits, diet and exercise.

Alzheimer's
A combination of different vitamin E forms could help prevent cognitive deterioration in advanced age, according to the results of a study published Journal of Alzheimer's Disease. The findings suggest that it is multiple components of the vitamin that could reduce the risk of developing Alzheimer’s. The population-based study aimed to evaluate whether higher plasma levels of vitamin E could be protective against Alzheimer’s in advanced age and whether the protective activity could be due to more than just the tocopherol form of the vitamin.

Vitamin E is a family of eight natural components, but most studies related to Alzheimer's disease investigate only one of these components – alpha tocopherol. The researchers hypothesized that all the vitamin E components could be important in protecting against AD than one alone.

At the start of the study, all participants were dementia-free. After six years, subjects with higher blood levels of all the vitamin E family forms had a reduced risk of developing AD, compared to subjects with lower levels. After adjusting for various confounders, the risk was reduced by 45-54 percent, depending on the vitamin E component.

Steve - elderly people as a group are large consumers of vitamin E supplements, which usually contain only alpha tocopherol, and this often at high doses. We have said for years that a balanced presence of different vitamin E forms (mixed tocopherols) can have an important neuroprotective effect. However, almost all of the research done on vitamin E has included just the one component, alpha tocopherol. For vitamin E to function therapeutically, except for a multivitamin, it should be provided in its full spectrum state.


Consuming more vitamin E through the diet also appears to be associated with a lower risk of dementia and Alzheimer's disease, according to Archives of Neurology. Oxidative stress, damage to the cells from oxygen exposure, is thought to play a role in the development of Alzheimer's disease. One-third of individuals who consumed the most vitamin E were 25 percent less likely to develop dementia than the one-third of participants who consumed the least.

NAFLD
Vitamin E was found to mitigate the more progressive form of
nonalcoholic fatty liver disease (NAFLD), reported in the Journal of the American Medical Association. The data suggests that children treated with vitamin E who had biopsy-proven nonalcoholic steatohepatitis (NASH) had significant improvement in secondary histologic outcomes with vitamin E. NAFLD has become the most common cause of chronic liver disease in children in the U.S.

Monday, September 26, 2011

Safest bone resorption medication more effective.

Oral recombinant salmon calcitonin tablets are more effective at improving lumbar spine bone mineral density (BMD) after 48 weeks than placebo or a nasal formulation of the hormone, according to the results of a phase 3 multinational double-blind trial. In the study, presented at the American Society for Bone and Mineral Research 2011 Annual Meeting, researchers compared the tablet form of salmon calcitonin with a nasal formulation and placebo in 565 postmenopausal women, 45 years or older, from 6 countries.

At baseline and at weeks 24 and 48, replicate dual-emission X-ray absorptiometry scans showed the oral formulation to be better than the nasal formulation at increasing BMD. In the oral group, lumbar spine BMD increased. In the nasal group, the increase was smaller, and in the placebo group the increase was not significant. At the exit visit, fasting carboxy-terminal collagen crosslink (CTx) serum levels, indicating bone resorption, decreased by 29.9%, 11.4%, and 11.8% in the oral, nasal, and placebo groups, respectively. Most adverse events were mild or moderate in severity.

The formulation is a combination of an organic acid and peptide, which are simultaneously released. It is designed with a coating that prevents opening in the acidic environment of the stomach, but subsequently dissolves in the neutral upper bowel. "It is encouraging to see new forms of osteoporosis treatment options becoming available for clinical use. I will be very interested in further research trials on oral salmon calcitonin," stated the Conference's chairman.

Wednesday, September 21, 2011

Wound Healing

Wound healing continues to be a major health care issue that consumes ever larger amounts of precious health care dollars. Surgeons, scientists, and pharmaceutical companies have been engaged in efforts to develop means of enhancing or modulating wound healing. That growth factors and cytokines play a major role in the unfolding of the wound healing response to injury is undisputed. Disappointingly, the application of purified growth factors onto wounds has met with almost universal failure in reversing or enhancing wound healing. Here are other therapies coming into focus:
Gene therapy
Bone marrow-derived, umbilical cord-derived, adipose-derived, and epidermal stem cells
Artificial skin which is a mixture of keratinocytes and/or fibroblasts embedded onto a collagen matrix has been in use for over a decade.

Closing Wounds
Wounds do not always need stitching. Simple laceration can be managed more quickly and less painfully with tissue adhesives than with sutures, staples, or adhesive tape - and the cosmetic results are equally good, according to a Cochrane Review involving more than 900 children and adults with acute linear lacerations. The trials compared one tissue adhesive against another or against a standard wound closure technique (sutures, staples, or adhesive tapes) for traumatic lacerations. Pain scores were lower with tissue adhesives, as was procedure time. Potential "downsides" of tissue adhesives relate to choosing the wrong wound to glue - the wound is under too much tension and will break open, the wound is infected and you're now sealing it in.

Stress Affects Healing
Psychological stress can affect wound healing in humans. Other psychological mediators, such as depression and anxiety, have been shown to slow wound healing and should be explored further. Psychological stress can lead to unhealthy behaviors which may impact wound healing such as smoking, poor nutrition, and altered sleep. Stress can negatively impact sleep, leading to disturbed sleep patterns and a reduction in growth hormones, which may down-regulate the tissue repair response. Although numerous factors play a role in whether or not a wound heals, such as nutrition, underlying health conditions and appropriate care, it is clear that cytokines play a crucial role as well. If dysregulation of the various cytokines occurs, a potential disruption of normal wound healing results, leading to delayed healing and increased risk of infection and wound complications. Wounds, August 2011

Natural Wound HealerA recent Wounds study found that honey accelerated the inflammatory reaction and initiates healing early on in the treatment process of skin wounds. Manuka honey, in particular, could be an efficient way to clear chronically infected wounds and could even help reverse bacterial resistance to antibiotics, according to research presented at the Society for General Microbiology. Three types of bacteria commonly infest wounds: Pseudomonas aeruginosa, Group A Streptococci and Meticillin-resistant Staphylococcus aureus (MRSA). Researchers have found that honey can interfere with the growth of these bacteria in a variety of ways and suggests that honey is an attractive option for the treatment of drug-resistant wound infections.

Wednesday, September 14, 2011

Colonoscopy too frequent: study

Most people who are at average risk for colorectal cancer and who have a negative colonoscopy probably do not need another screening colonoscopy for at least 20 years, if they need one at all, researchers suggest in a study published August 29 in the Journal of Clinical Oncology. The study brought out immediate detractors, saying they would be very apprehensive about anybody taking the information from this study and jumping to a conclusion that colonoscopy screening can be deferred for 20 years. Certainly, from 1 study, that would be an inappropriate conclusion.

The researchers recruited 1945 patients with colorectal cancer and 2399 control subjects from 22 hospitals and population registers in the Rhine-Neckar region of Germany from 2003 to 2007. They collected data on history of colonoscopy, age, sex, years of education, history of colorectal cancer among first-degree relatives, smoking, use of nonsteroidal anti-inflammatory drugs, use of hormone replacement therapy, and previous participation in a general health screening examination. After controlling for these factors, the researchers found that a previous negative colonoscopy was associated with a strongly reduced risk for colorectal cancer, and that very low risks continued for 20 years or more. The researchers report that adjusted odds ratios were very low for left-sided and right-sided cancers for more than 20 years after a negative colonoscopy. A negative colonoscopy is of great clinical value. "Our results suggest that, despite not being preventive by itself, a negative colonoscopy is of great clinical value, because people with such a result can be assured of being at a low risk of [colorectal cancer] for a long time. "Furthermore, the finding of sustained low risk for 20 years and beyond after a negative colonoscopy suggests that a screening colonoscopy might not need to be repeated after 10 years as was previously recommended."

The researchers conclude by suggesting that the possibility of extending screening intervals beyond 10 years, "perhaps even among people with a positive family history," could make colonoscopy screening more cost effective and reduce complications associated with the procedure. Extending the interval could also make population-wide colonoscopic screening feasible in countries that have limited resources for high-quality colonoscopies, they add.

Long-term use of mobile phones takes another hit

This study's analyses suggest that there is an increase in glioma risk with higher levels of Radio Frequency (RF) dose in people whose brain has absorbed high levels of RF energy from mobile phone use and that this risk may only be evident in people who began mobile phone use 7–10 years or more before diagnosis. There is a possibility also of similar, but apparently much smaller, increases in meningioma risk. Uncertainties around these results require that they are replicated before they can be considered to be real. The best way to replicate them would be to repeat this analysis in data from the other eight Interphone countries and in future studies with longer latency periods and higher cumulative exposures. Occupational & Environmental Medicine September 2011


Is SAD Affecting You?

Winter may not the saddest time of the year. Springtime may be much worse.

Many see seasonal affective disorder (SAD) as synonymous with winter depression. However, depression is only half of the problem. Spring and summer mania tend to be ignored. Beginning with winter depression, core symptoms resemble hibernation. People sleep more, eat more, and are less interested in usual activities. They are not sad in mood, typically, and may be unaware that their slowed down, uninterested behavior reflects a kind of depression. A number of misconceptions are harbored about winter depression. The most frequent, perhaps, is that it has to do with coldness of temperature. Winter depression is not about shivering and freezing. These do not cause depression. Decreased light does.

It doesn't matter whether it's 70°F or 20°F outside. If there are 10 hours of light in a day rather than 14, then seasonal depression will follow. Moreover, light itself is not the only cause of depression.
This is why many people who live in Florida still have SAD. Light interacts with a person's own sensitivity to depression. Some people, especially those with bipolar disorder or recurrent unipolar depression, are sensitive to changes in light, and will develop winter depression even in areas with reasonable light levels. Others are insensitive to light, and will not develop SAD even in areas with low light levels.

Diagnosing SAD
This leads to another misconception about SAD. It is a diagnosis of exclusion, and should not be diagnosed in persons with bipolar disorder or recurrent unipolar depression. The mood episodes that characterize those conditions can happen any time of year; they are just more likely in winter (for depression) and summer (for mania). SAD means someone has only depression in the winter, and almost never has depression any other time of year.

Most people who think that they have SAD don't. If they have severe depression, their winter depressive episodes are usually part of a larger illness, whether bipolar or unipolar. Commonly, however, people think that they have SAD because indeed they have winter depressive-like symptoms, but not full clinical depressive episodes. This experience, sometimes called "winter blues," is common, and occurs in the general population at a frequency that varies depending on latitude: approximately 1% in Florida, 5% in the mid-Atlantic, and 10% in New England. Again, we can understand this prevalence as reflecting an interaction of light with the biological sensitivity of individuals to light.

Light and Mood
What does light do to cause changes in mood? Light entrains our circadian rhythms; it is what keeps us on regular sleep-wake cycles. When sleep is impaired and reduced, an antidepressant effect occurs, and, in sensitive persons, mania materializes. This is what takes place in the spring and summer when light greatly increases. Longer duration of sleep leads to depression in sensitive persons. Circadian cycles appear to be biologically abnormal in people with bipolar disorder and recurrent depression, hence their sensitivity to light. One of the effects of lithium, for instance, is to lengthen circadian cycles. In most of us, these changes do not affect our moods. In others, they do.

Warding Off Seasonal Depression
Besides light box treatment for seasonal depression, in winter. increase your exposure to light as much as possible. Go out for a walk at noon for up to an hour without any sunglasses on. Sleep with all the blinds up. In summer. reduce your exposure to light as much as possible. Always wear sunglasses, get room-darkening shades, and sleep in as much darkness as possible. It is key to adjust one's exposure to natural morning sunlight. It is amazing how many people who oversleep never think of pulling up their window shades, and how many people who don't sleep enough don't think about getting room-darkening window shades.

Vitamin D Deficiency
A daily dose of vitamin D may just be what people in northern climates need to get through the long winter, according to researchers at Loyola University Chicago Marcella Niehoff School of Nursing. Diet alone may not be sufficient to manage vitamin D levels. A combination of adequate dietary intake of vitamin D, exposure to sunlight, and treatment with vitamin D3 supplements can decrease the risk of certain health concerns.

Loyola faculty members plan to take vitamin D research a step further by evaluating whether weekly vitamin D supplements improve blood sugar control and mood in women with diabetes. Depression is associated with increased insulin resistance, so people with diabetes have a greater risk for the disease than those without depression. Women also tend to have greater rates of depression and poorer blood sugar control than men with diabetes.


Light Box Treatment
Light box treatment essentially replaces the sunlight that is missing in wintertime. Most light boxes provide about 10,000 lux of light, and are meant to be used in the mornings, which is when the sun would normally have risen earlier than it does in the depths of winter. Patients should read or eat breakfast while exposed to indirect light from the box at about arm's length for about 30 minutes daily. Just as one does not directly look at the sun, patients should not directly look at light boxes; this causes ocular damage. The amount of time with light box treatment can be increased or decreased as needed for antidepressant effect, which, unlike drugs, occurs quickly: usually within 1-2 weeks. If the you improve, the light box can be reduced in frequency or duration to the minimum amount that seems to be needed. Usually, the decline in light starts in October-November, and that is when light box treatment can begin. Light then increases in March-April, and by then light box treatment should be stopped.

Can Too Much Light Be Harmful?
"April is the cruelest month," T.S. Eliot famously said. Most people think of SAD only in terms of winter depression, but springtime mania should not be ignored, especially because mania frequently reflects mixed states, when depression and mania occur together, and mixed states are linked with the highest risk for suicide. Winter suicide rates are quite low. The highest suicide rates in the United States have always been in the sunny West, specifically California, and particularly the sunniest part of California: San Diego County. It's been this way for 100 years, despite all kinds of cultural and social changes. Obviously suicide is an olio of many ingredients, but could a biological catalyst be the dark side of SAD: too much light? Whatever the case, we know that too little light can cause depression in people who are sensitive to it, especially those who already have mood diseases. However, let's not forget that too much light is, in many ways, just as bad. January may be an unhappy month, but April is the cruelest.

Wednesday, September 7, 2011

Prostate Update

Biopsy
Needle biopsies that follow an abnormally high PSA reading are increasingly resulting in infection by antibiotic-resistant strains of bacteria such as E. coli. Research shows that the risk of post-biopsy infection - while still small - has more than doubled in less than a d

Diet

Coffee contains many biologically active compounds, including caffeine and phenolic acids, that have potent antioxidant activity and can affect glucose metabolism and sex hormone levels. Because of these biological activities, coffee may be associated with a reduced risk of prostate cancer. Of 47,911 men in the Health Professionals Study, a strong inverse association between coffee consumption and risk of lethal prostate cancer. The association appears to be related to non-caffeine components of coffee. Journal of the National Cancer Institute. September 2011
Environment
An American Journal of Epidemiology study provides evidence of an association between prostate cancer and ambient pesticide exposures in and around homes in intensely agricultural areas. The associations appear specific to compounds with a plausible biologic role in prostate carcinogenesis.


EstrogenIn vivo and in vitro studies have identified multiple mechanisms of potential carcinogenesis, including direct genotoxicity, epigenotoxicity, hyperproloctinemia, chronic inflammation and prostatic ER-mediated changes that are in addition subject to disruption by environmental estrogens. Moreover, ample evidence for estrogen's role in the development of human prostate cancer exists in the form of epidemiological data and associations between inflammation and cancer. According to commentary in Expert Review of Endocrinology and Metabolism. The true role of estrogen in prostate cancer development and progression is probably complex and multifactorial, incorporating more than one of the mechanisms already described and with interplay between them. Although circulating estrogen levels may not correlate well with intraprostatic levels, particularly in light of recent evidence of intraprostatic estrogen production, serum values offer an easily accessible surrogate marker to investigate associations between estrogen and prostate cancer risk.

Other Cancers From Prostate Therapy
Men treated with hormone-based therapy for prostate cancer faced a 30 percent to 40 percent higher risk of colorectal cancer, compared to patients who did not receive this treatment. This study looked at use of androgen deprivation therapy, a common type of treatment for prostate cancer that involves blocking the male hormone testosterone through either surgical removal of the testicles or a series of injections.
Patients who had their testicles removed, a procedure called orchiectomy, had the highest rates of colorectal cancer. Researchers looked at data from 107,859 men aged 67 and older with prostate cancer. Results of the study were published online in the Journal of the National Cancer Institute.

Pharmaceuticals
The FDA recently approved Provenge (autologous cellular immunotherapy)
designed to use your immune system to fight prostate cancer. It is the first medication with this action to be approved. While promising, we still say give it the two-year rule before trying unless cancer is advanced.

The FDA has issued a warning of an increased risk of high-grade prostate cancer with the 5-alpha reductase inhibitors finasteride (Proscar) and dutasteride (Avodart) currently approved to treat benign prostatic hypertrophy. The agency announced that it has updated the Warnings and Precautions section of labels for the class of drugs -- which includes branded products Propecia and Jalyn under which finasteride and dutasteride are marketed for other indications -- to reflect the increased risk. Avodart, Jalyn, and Proscar are approved to treat symptoms of an enlarged prostate. Propecia, at a 1-mg dose, is approved to treat hair loss in men. The announcement follows the FDA's Oncologic Drugs Advisory Committee vote of 17-0 in that GlaxoSmithKline's dutasteride and Merck's finasteride should not be used to prevent prostate cancer because the drugs are linked to a higher incidence of high-grade tumors.

Procedure Conundrum
Researchers claim in a study from journal Cancer Cell that when a common type of prostate cancer was treated with conventional hormone ablation therapy blocking androgen production or androgen receptor (AR) function- which drives growth of the tumor -- the cancer was able to adapt and compensate by activating a survival cell signaling pathway, effectively circumventing the roadblock put up by this treatment. The findings could have important clinical implications as this type of prostate cancer, in which the PTEN tumor suppressor gene is inactivated, accounts for about 40 to 50 percent of primary prostate cancers and 70 to 90 percent of cancers that become resistant to hormone therapy, called castration resistant prostate cancers.

Based on this study, these prostate cancers could be more effectively treated using a combination of drugs that target the AR cell signaling pathway and the compensating survival pathway. The most significant take home message from the study is that certain prostate cancers can resist androgen deprivation therapy by activating an alternate pathway to drive its growth. When we suppress one of these pathways, it essentially feeds the other.

Men who die of prostate cancer are those that become resistant to hormone ablation therapy and, as a consequence, their disease can spread or metastasize to other places, most often the bones. Clinical trials currently are being designed at that will combine these types of drugs to cut off both the primary path and escape routes that prostate cancers use to survive.

Screening Tools: Out With the Old, In With the New
A+PSA assay, a new test for prostate cancer that measures levels of prostate specific antigen (PSA) as well as six specific antibodies found in the blood of men with the disease was more sensitive and more specific than the conventional PSA test used today, according to a study from Journal of Translational Medicine. The study focused on six specific prostate-cancer associated antigens -- NY-ESO-1, SSX-2,4, XAGE-lb, AMACR, p90 and LEDGF -- which are found predominantly in patients with prostate cancer and not in benign prostate conditions. The percentage of men with prostate cancer who were correctly identified as having a malignancy -- was 79 percent compared to the 52 percent found in PSA testing.

Researchers report that nearly half of men in their seventies underwent PSA screening in the past year -- almost double the screening rate of men in their early fifties, who are more likely to benefit from early prostate cancer diagnosis and treatment. Further, men aged 85 and older were screened just as often as men in their early fifties. Because prostate cancer tends to be slow-growing, data show that many men -- particularly those in their seventies and older -- will die of other causes before prostate cancer becomes a problem that requires medical attention. Published in the Journal of Clinical Oncology, the new findings underscore a long-standing concern that overuse of PSA screening and PSA-based treatment decisions may lead to unnecessary treatment of many older men and potential complications such as incontinence, impotence and bowel dysfunction.


Related Blog Posts
Predicting Prostate Cancer With a Genetic Variation
Predicting Prostate Cancer With a Genetic Variation



The views expressed in these blog posts are those of the author and not of the Sun-Times News Group.

Hand stiffness? Chondroitin helps.

New research shows that chondroitin sulfate significantly decreased pain and improved hand function in patients with osteoarthritis (OA) of the hand compared with those in the placebo group. Results of the clinical trial available in Arthritis & Rheumatism. Chondroitin sulfate also improved grip strength and relieves morning stiffness. Approximately 10% of the world population, 60 years and older, have symptomatic osteoarthritis according to the Global Burden of Disease report from the World Health Organization (WHO).

Friday, September 2, 2011

Sucralose (Splenda) found in municipal wastewater

The artificial sweetener sucralose has been detected in municipal wastewater effluent and surface waters at concentrations ranging from ng/L to low μg/L. Few chronic ecotoxicological data are available in the peer reviewed literature with respect to sucralose. To address this data gap mysid shrimp studies were conducted to assess the effects of sucralose on the survival, growth and reproduction of these organisms. Concentrations 1800 mg/L resulted in no statistically significant reduction in D. magna survival or reproduction. Survival, growth and reproduction of mysid shrimp were unaffected by 93 mg/L sucralose. The no observable effect concentration (NOEC) and lowest observable effect concentration (LOEC) for the D. magna study were 1800 and >1800 mg/L, respectively. Collectively, these data suggest that the concentrations of sucralose detected in the environment are well below those required to elicit chronic effects in freshwater or marine invertebrates. American Journal Preventive Medicine September, 2011

Steve - the reason we posted this study is to show you that artificial sweeteners are exactly that...artificial.

Hi Protein, Low Glycemic Rules

A September study from Evidence Based Medicine followed 1209 overweight and obese adults (body mass index between 27 and 45) from eight European countries. Eligible participants were aged between 18 and 65 and had at least one healthy child. They were invited to take part in an 8-week low-calorie diet, and those who achieved at least an 8% weight loss were eligible to participate in a 6-month weight-loss maintenance trial. Of the 938 who took part in the diet, 773 were then randomized to one of four dietary maintenance interventions: a high protein (25% of energy) or a low protein (13% of energy), with either a high-GI (glycemic index) diet or low-GI diet (15 GI units lower than high GI); alternatively, they were randomized to a control diet with an average protein level. Fat content was 25–30% of energy. The outcomes reported in this article were weight, fat and lean mass, waist and hip circumference and 24 h urinary urea and plasma urea.

This remarkably successful study has shown that a family-focused intervention can achieve an 11 kg weight loss and maintain nearly all of it for 6 months. This study has confirmed previous shorter and smaller studies that show that increasing protein and lowering GI increases weight loss or weight maintenance by about 0.6–1 kg for each intervention and that the two changes are entirely additive. This study has also shown that advising people to increase their protein intake is relatively ineffective in achieving an increase in protein and enhancing weight maintenance, whereas providing high-protein foods is effective as has been previously shown. The reverse was shown with GI: providing low-GI foods was ineffective relative to high-GI foods, while asking people to choose low-GI foods enhanced dietary compliance. This finding suggests the GI of foods per se has no impact on weight maintenance which differs from the authors' conclusions. In their discussion, the authors confuse GI and glycemic load (GL). There is better evidence that lowering GL by lowering carbohydrate, increasing protein and lowering GI has more of an effect on weight than lowering GI without changing the carbohydrate amount.

Thursday, September 1, 2011

One issue with flavanoids

Flavonoids are polyphenolic compounds of natural occurrence produced by plants that are largely consumed both for therapeutic purposes and as food. Experimental data have shown that many flavonoids could inhibit thyroperoxidase activity, decreasing thyroid hormones levels thus increasing TSH and causing goiter. In humans, infants fed with soy formula have been shown to develop goiter. However, in post-menopausal women soy intake did not affect thyroid function. In thyroid tumor cell line, flavonoids were shown to inhibit cell growth, but they can also decrease radioiodine uptake, that could reduce the efficacy of radioiodine therapy. Flavonoids could also affect the availability of thyroid hormones to target tissues, by inhibiting deiodinase activity or displacing T4 from transthyretin. Thus, flavonoids have been shown to interfere with many aspects of the thyroid hormones synthesis and availability in in vivo and in vitro models. If you consume a high amount of flavanoids and struggle with thyroid issues, discuss with your health professional to see flavanoid intake should be ruled out. American Journal Preventive Medicine September, 2011